Search Results - "Toh, Wu Han"

Incubation Period and Serial Interval of Mpox in 2022 Global Outbreak Compared with Historical Estimates by Ponce, Luis, Linton, Natalie M, Toh, Wu Han, Cheng, Hao-Yuan, Thompson, Robin N, Akhmetzhanov, Andrei R, Dushoff, Jonathan

“…Understanding changes in the transmission dynamics of mpox requires comparing recent estimates of key epidemiologic parameters with historical data. We derived…”
Get full text

Targeting type 2 inflammation in bullous pemphigoid: current and emerging therapeutic approaches by Toh, Wu Han, Lee, Hua-En, Chen, Chun-Bing

“…Bullous pemphigoid (BP) is one of the most common autoimmune bullous diseases and mainly affects an elderly population with multi-morbidity. Due to the frailty…”
Get full text

Machine Learning Elucidates Design Features of Plasmid Deoxyribonucleic Acid Lipid Nanoparticles for Cell Type-Preferential Transfection by Cheng, Leonardo, Zhu, Yining, Ma, Jingyao, Aggarwal, Ataes, Toh, Wu Han, Shin, Charles, Sangpachatanaruk, Will, Weng, Gene, Kumar, Ramya, Mao, Hai-Quan

“…To broaden the accessibility of cell and gene therapies, it is essential to develop and optimize nonviral, cell type-preferential gene carriers such as lipid…”
Get full text

Optimization of lipid nanoparticles for gene editing of the liver via intraduodenal delivery by Zhu, Yining, Cai, Shuting Sarah, Ma, Jingyao, Cheng, Leonardo, Wei, Christine, Aggarwal, Ataes, Toh, Wu Han, Shin, Charles, Shen, Ruochen, Kong, Jiayuan, Mao, Shuming Alan, Lao, Yeh-Hsing, Leong, Kam W., Mao, Hai-Quan

“…Lipid nanoparticles (LNPs) have recently emerged as successful gene delivery platforms for a diverse array of disease treatments. Efforts to optimize their…”
Get full text

Advancing Treatment in Bullous Pemphigoid: A Comprehensive Review of Novel Therapeutic Targets and Approaches by Chen, Hsuan-Chi, Wang, Chuang-Wei, Toh, Wu Han, Lee, Hua-En, Chung, Wen-Hung, Chen, Chun-Bing

“…Bullous pemphigoid is one of the most common autoimmune bullous diseases occurring primarily in the elderly. Pathogenic autoantibodies against BP180 and BP230…”
Get full text

Screening for lipid nanoparticles that modulate the immune activity of helper T cells towards enhanced antitumour activity by Zhu, Yining, Ma, Jingyao, Shen, Ruochen, Lin, Jinghan, Li, Shuyi, Lu, Xiaoya, Stelzel, Jessica L., Kong, Jiayuan, Cheng, Leonardo, Vuong, Ivan, Yao, Zhi-Cheng, Wei, Christine, Korinetz, Nicole M., Toh, Wu Han, Choy, Joseph, Reynolds, Rebekah A., Shears, Melanie J., Cho, Won June, Livingston, Natalie K., Howard, Gregory P., Hu, Yizong, Tzeng, Stephany Y., Zack, Donald J., Green, Jordan J., Zheng, Lei, Doloff, Joshua C., Schneck, Jonathan P., Reddy, Sashank K., Murphy, Sean C., Mao, Hai-Quan

“…Lipid nanoparticles (LNPs) can be designed to potentiate cancer immunotherapy by promoting their uptake by antigen-presenting cells, stimulating the maturation…”
Get full text